AKAP13 siRNA (Human)
SiRNA to inhibit AKAP13 expression using RNA interference
Product Specifications
Product Name Alternative
BRX; HT31; LBC; A-kinase anchor protein 13; AKAP-13; AKAP-Lbc; Breast cancer nuclear receptor-binding auxiliary protein; Guanine nucleotide exchange factor Lbc; Human thyroid-anchoring protein 31; Lymphoid blast crisis oncogene; LBC oncogene; Non-oncogenic Rho GTPase-specific GTP exchange factor; Protein kinase A-anchoring protein 13; PRKA13; p47
Reactivity
Human
Source
Synthetic
Field of Research
Signal Transduction
Purity
> 97%
Form
Liquid
Storage Conditions
Shipped at 4 °C. Store at -20 °C for one year.
Notes
For research use only.
Applications Notes
Components: We offers pre-designed sets of 3 different target-specific siRNA oligo duplexes of human AKAP13 gene. Each vial contains 5 nmol of lyophilized siRNA. The duplexes can be transfected individually or pooled together to achieve knockdown of the target gene, which is most commonly assessed by qPCR or western blot. Directions for Use: We recommends transfection with 10 nM - 100 nM siRNA 48 to 72 hours prior to cell lysis. Before resuspending, briefly centrifuge the tube to ensure the lyophilized siRNA is at the bottom of the tube. Resuspend the siRNA oligos to an appropriate concentration with DEPC water. For example, resuspend one tube of 5 nmol siRNA oligo in 250 μl of DEPC water to get a final concentration of 20 μM
Tested Applications
RNA-I
Entrez
0, 11214
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog